Cefoperazone plus mezlocillin for empiric therapy of febrile cancer patients.

Jones, P; Bodey, G P; Rolston, K; Fainstein, V; Riccardi, S

Jones, P; Bodey, G P; Rolston, K; Fainstein, V; Riccardi, S.

Affiliation

Jones P; Department of Medical Specialities, University of Texas M.D. Anderson Cancer Center, Houston 77030.

Am J Med ; 85(1A): 3-8, 1988 Jul 25.

Article in En | MEDLINE | ID: mdl-3400680

Subject(s)

Cefoperazone/administration & dosage; Fever/complications; Mezlocillin/administration & dosage; Neoplasms/complications; Adolescent; Adult; Aged; Bacteria/drug effects; Bacterial Infections/complications; Bacterial Infections/drug therapy; Bacterial Infections/prevention & control; Cefoperazone/adverse effects; Cefoperazone/pharmacology; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Leukocyte Count; Male; Mezlocillin/adverse effects; Mezlocillin/pharmacology; Microbial Sensitivity Tests; Middle Aged; Neoplasms/blood; Neutrophils

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Cefoperazone / Fever / Mezlocillin / Neoplasms Type of study: Clinical_trials Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Am J Med Year: 1988 Document type: Article

Search on Google

Add to My VHL

XML

PubMed Links